Millennium Management
AYLA

Millennium Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Millennium Management’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,913
Closed -$15K – 7978
2022
Q3 		$15K Sell
14,913
-15,657
-51% -$21.1K ﹤0.01% 6553
2022
Q2 		$33K Sell
30,570
-41,947
-58% -$95.8K ﹤0.01% 6334
2022
Q1 		$289K Buy
+72,517
New +$377K ﹤0.01% 5582
2021
Q2 		– Sell
-12,407
Closed -$135K – 7466
2021
Q1 		$135K Sell
12,407
-8,695
-41% -$124K ﹤0.01% 5619
2020
Q4 		$240K Sell
21,102
-15,325
-42% -$177K ﹤0.01% 4704
2020
Q3 		$429 Sell
36,427
-25,359
-41% -$297K ﹤0.01% 3656
2020
Q2 		$620K Buy
+61,786
New +$859K ﹤0.01% 3275

Other funds holding AYLA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $3.64B AUM 14.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return